Atom Investors’s DNA X Inc SONM Stock Holding History

Atom Investors’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-154	Closed	-$3.52M	–	413
2019 Q2	$3.52M	Buy	+154	New	+$3.91M	0.23%	134

Other funds holding SONM

Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Atom Investors's SONM Position: Q3 2019 in Review

Atom Investors sold out of DNA X Inc (SONM) in Q3 2019, closing a stake of 154 shares — an estimated $3.52M sold.

Atom Investors first reported a position in SONM in Q2 2019 and held it in 1 quarter. The position peaked at $3.52M in Q2 2019. 33 funds tracked by Wall St. Rank hold SONM as of Q3 2019.

Atom Investors reported no remaining DNA X Inc position as of Q3 2019 after selling out during the quarter.
Atom Investors sold 154 DNA X Inc shares in Q3 2019, an estimated $3.52M.
Atom Investors first reported a position in DNA X Inc in Q2 2019 and held it in 1 quarter.
Atom Investors's DNA X Inc position peaked at $3.52M in Q2 2019.
33 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2019.

Based on Atom Investors's 13F filing for Q3 2019, filed 14 Nov 2019.